Tiffany Riser, NP
Nurse Practitioner · Baltimore
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 14 years
- Graduated 2012
Offices
2 locations · Johns Hopkins Community Physicians, Inc · 764 clinicians in this group
Looking this up.
Hospitals listed: 217081 · 211526 · Johns Hopkins Hospital, the. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Tiffany Riser’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Johns Hopkins Hospital, theBaltimore, MDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Johns Hopkins Health System, which runs 6 hospitals in 3 statesHome of Sidney Kimmel Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 1.84 (1.19 to 2.49) · 4,951 cases, Jul 2022 – Jun 2024Worse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.17 (1.01 to 1.32), Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.3 (11.7 to 15.1) · 1,609 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.605, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.358, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.302, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 4 (3.2 to 5) · 1,609 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Johns Hopkins Hospital, the
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 4 better, 2 the same, 1 worse of 7 measures. Readmissions: 1 better, 6 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.84 (1.19 to 2.49) · 4,951 cases | Worse | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.17 (1.01 to 1.32) | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.3 (11.7 to 15.1) · 1,609 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.605 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.358 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.302 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (3.2 to 5) · 1,609 cases | Better | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 160.59 (131.83 to 189.35) · 409 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.4 · 266 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 5.7 · 173 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 563 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 8.9 · 377 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.1 · 283 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.5 · 4,532 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.36 (0.2 to 0.51) · 17,508 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.14 to 0.45) · 19,518 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (3.36 to 5.72) · 6,562 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.87 (1 to 2.74) · 4,318 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.32 (1.41 to 3.23) · 5,830 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.82 (7.25 to 12.39) · 4,056 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (3.33 to 6.69) · 4,266 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.42 (0.26 to 2.59) · 2,087 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0.52 to 1.18) · 17,435 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.819 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.654 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.829 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.4 · 182 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 682 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.6 · 189 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -15.5 · 647 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 45.6 · 396 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 406 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 245 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,351 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,483 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,167 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 195 Part D prescriptions in 2015.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2015 | 195 | 29 | 0% (0) | 12% | $11,140 |
| 2014 | 1,702 | 95 | 4% (63) | None | $116,291 |
| 2013 | 1,906 | 128 | 8% (151) | 21% | $122,628 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2015: 4 drugs
| Pravastatin | 19 | $427 | $22 |
| Hydrochlorothiazide | 17 | $173 | $10 |
| Clopidogrel | 11 | $123 | $11 |
| Alendronate | 11 | $112 | $10 |
2014: 49 drugs
| Namenda | 59 | $19,389 | $329 |
| Namenda Xr | 25 | $9,608 | $384 |
| Lidocaine | 14 | $4,029 | $288 |
| Xarelto | 13 | $3,829 | $295 |
| Symbicort | 11 | $2,870 | $261 |
| Lantus | 13 | $2,795 | $215 |
| Famotidine | 15 | $2,716 | $181 |
| Bystolic | 12 | $1,049 | $87 |
| Pravastatin | 43 | $892 | $21 |
| Oxycodone-Acetaminophen | 15 | $809 | $54 |
| Omeprazole | 20 | $794 | $40 |
| Clopidogrel | 24 | $717 | $30 |
| Polyethylene Glycol 3350 | 26 | $709 | $27 |
| Buspirone | 15 | $669 | $45 |
| Levothyroxine | 39 | $638 | $16 |
| Mirtazapine | 45 | $632 | $14 |
| Gabapentin | 41 | $628 | $15 |
| Amlodipine Besylate | 63 | $626 | $10 |
| Citalopram Hbr | 62 | $587 | $9 |
| Hydralazine | 24 | $582 | $24 |
| Carbidopa-Levodopa | 19 | $534 | $28 |
| Metoprolol | 14 | $529 | $38 |
| Donepezil | 30 | $479 | $16 |
| Hydrocodone-Acetaminophen | 21 | $445 | $21 |
| Metformin | 40 | $427 | $11 |
| Hydrochlorothiazide | 42 | $413 | $10 |
| Paroxetine | 19 | $271 | $14 |
| Baclofen | 13 | $269 | $21 |
| Sulfamethoxazole-Trimethoprim | 17 | $258 | $15 |
| Metoprolol | 39 | $238 | $6 |
| Atorvastatin | 14 | $226 | $16 |
| Primidone | 12 | $212 | $18 |
| Warfarin | 37 | $209 | $6 |
| Losartan | 23 | $203 | $9 |
| Simvastatin | 26 | $198 | $8 |
| Alprazolam | 15 | $184 | $12 |
| Trazodone | 20 | $170 | $9 |
| Pantoprazole | 16 | $158 | $10 |
| Carvedilol | 18 | $158 | $9 |
| Lorazepam | 20 | $135 | $7 |
| Alendronate | 14 | $133 | $9 |
| Allopurinol | 16 | $113 | $7 |
| Lisinopril | 20 | $108 | $5 |
| Fluoxetine | 11 | $104 | $9 |
| Prednisone | 15 | $98 | $7 |
| Glipizide Er | 11 | $93 | $8 |
| Sulindac | 11 | $84 | $8 |
| Atenolol | 17 | $71 | $4 |
| Furosemide | 17 | $64 | $4 |
2013: 60 drugs
| Namenda | 93 | $25,949 | $279 |
| Oxycontin | 13 | $8,902 | $685 |
| Januvia | 18 | $6,510 | $362 |
| Diovan | 40 | $5,663 | $142 |
| Spiriva | 15 | $4,051 | $270 |
| Temazepam | 16 | $3,950 | $247 |
| Nexium | 14 | $3,719 | $266 |
| Symbicort | 15 | $3,622 | $241 |
| Lantus | 14 | $2,617 | $187 |
| Omeprazole | 38 | $1,742 | $46 |
| Midodrine | 16 | $1,512 | $94 |
| Escitalopram | 13 | $1,142 | $88 |
| Gabapentin | 42 | $1,020 | $24 |
| Nystop | 12 | $995 | $83 |
| Hydrocodone-Acetaminophen | 59 | $893 | $15 |
| Amlodipine Besylate | 67 | $859 | $13 |
| Citalopram Hbr | 79 | $749 | $9 |
| Clopidogrel | 16 | $734 | $46 |
| Carbidopa-Levodopa | 17 | $689 | $41 |
| Quetiapine | 12 | $679 | $57 |
| Diazepam | 15 | $579 | $39 |
| Polyethylene Glycol 3350 | 22 | $571 | $26 |
| Hydralazine | 17 | $546 | $32 |
| Levothyroxine | 43 | $489 | $11 |
| Oxycodone | 17 | $480 | $28 |
| Lorazepam | 41 | $459 | $11 |
| Metoprolol | 13 | $433 | $33 |
| Mirtazapine | 26 | $421 | $16 |
| Ibuprofen | 16 | $417 | $26 |
| Finasteride | 11 | $388 | $35 |
| Zolpidem | 23 | $387 | $17 |
| Nystatin | 16 | $376 | $24 |
| Simvastatin | 32 | $343 | $11 |
| Torsemide | 17 | $332 | $20 |
| Letrozole | 12 | $305 | $25 |
| Donepezil | 17 | $304 | $18 |
| Metoprolol | 48 | $300 | $6 |
| Tamsulosin | 19 | $296 | $16 |
| Warfarin | 31 | $291 | $9 |
| Oxycodone-Acetaminophen | 29 | $272 | $9 |
| Sulfamethoxazole-Trimethoprim | 27 | $261 | $10 |
| Baclofen | 20 | $259 | $13 |
| Metformin | 20 | $249 | $12 |
| Lisinopril | 38 | $236 | $6 |
| Paroxetine | 12 | $219 | $18 |
| Clonidine | 12 | $209 | $17 |
| Pravastatin | 12 | $188 | $16 |
| Clonazepam | 22 | $187 | $9 |
| Alprazolam | 16 | $177 | $11 |
| Isosorbide Mononitrate Er | 14 | $156 | $11 |
| Trazodone | 30 | $143 | $5 |
| Glipizide Er | 13 | $135 | $10 |
| Allopurinol | 21 | $120 | $6 |
| Famotidine | 18 | $120 | $7 |
| Amitriptyline | 16 | $115 | $7 |
| Carvedilol | 13 | $115 | $9 |
| Hydrochlorothiazide | 21 | $104 | $5 |
| Sulindac | 11 | $92 | $8 |
| Furosemide | 22 | $91 | $4 |
| Ciprofloxacin | 12 | $72 | $6 |
Professional record
- NPI
- 1578819629
- Licence
- VA 0024170223
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 6201 Greenleigh Ave, Middle River, MD, 21220
- NPI first listed
- 2012-07-26
- NPI last updated
- 2025-05-20
- NPI record certified
- 2025-05-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 600 N Wolfe St, Baltimore, MD, 21287